MedTrace Logo

Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia

NCT02865421 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2018-01-11

No results posted yet for this study

Summary

Androgenetic alopecia (AGA) is a common form of hair loss in both men and women, characterized by progressive patterned loss of hair from the scalp. The current study has been designed for restoration of hair in AGA by using a combination of stromal vascular fraction (derived from the adipose tissue) and human platelet rich plasma.

Conditions

  • Combination of SVF and PRP for Androgenetic Alopecia

Interventions

DRUG

stem cells

adipose tissue derived stromal vascular fraction

DRUG

platelet rich plasma

platelet rich plasma transplanted in bald area at a distance

Sponsors & Collaborators

  • King Edward Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-10
Primary Completion
2017-08-12
Completion
2017-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02865421 on ClinicalTrials.gov